IRIS
VAGHI, GLORIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 809
AS - Asia 623
EU - Europa 440
SA - Sud America 98
Continente sconosciuto - Info sul continente non disponibili 70
AF - Africa 32
Totale 2.072
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 787
SG - Singapore 194
CN - Cina 177
VN - Vietnam 86
RU - Federazione Russa 82
BR - Brasile 77
IT - Italia 77
HK - Hong Kong 74
DE - Germania 66
IE - Irlanda 65
FR - Francia 38
GB - Regno Unito 32
FI - Finlandia 28
IN - India 22
BD - Bangladesh 21
ZA - Sudafrica 19
CA - Canada 10
AT - Austria 9
JP - Giappone 9
MX - Messico 8
NL - Olanda 8
IQ - Iraq 7
PL - Polonia 7
ES - Italia 6
CO - Colombia 5
ID - Indonesia 5
AR - Argentina 4
CZ - Repubblica Ceca 4
MA - Marocco 4
SE - Svezia 4
CH - Svizzera 3
EC - Ecuador 3
PK - Pakistan 3
TN - Tunisia 3
TR - Turchia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
BH - Bahrain 2
CL - Cile 2
GR - Grecia 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
PE - Perù 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
Totale 2.002
Salva come PNG Salva come JPEG
Città #
San Jose 113
Singapore 100
Ashburn 92
Hong Kong 72
Dallas 70
Council Bluffs 66
Dublin 65
Beijing 57
Chandler 51
Los Angeles 40
Munich 27
Boardman 24
Lauterbourg 23
Milan 21
Hanoi 20
Ho Chi Minh City 20
Johannesburg 18
Shanghai 18
Helsinki 16
New York 16
Santa Clara 15
Moscow 14
Frankfurt am Main 12
São Paulo 12
Turku 12
Buffalo 10
Columbus 10
London 10
Redondo Beach 10
Rome 10
Brooklyn 9
Phoenix 9
Tokyo 9
Orem 8
Düsseldorf 7
Warsaw 7
Falkenstein 6
Lawrence 6
Medford 6
Mexico City 6
Princeton 6
The Dalles 6
Boston 5
Chennai 5
Da Nang 5
Atlanta 4
Belo Horizonte 4
Cuiabá 4
Dhaka 4
Medellín 4
Nuremberg 4
Poplar 4
Stockholm 4
Amsterdam 3
Chicago 3
Cremona 3
Denver 3
Hefei 3
Hyderabad 3
Manchester 3
Mumbai 3
Ninh Bình 3
Piscataway 3
Portsmouth 3
Secaucus 3
Serra 3
Seveso 3
Toronto 3
Vienna 3
Wilmington 3
Amman 2
Ankara 2
Athens 2
Baghdad 2
Bishkek 2
Bologna 2
Brasília 2
Campinas 2
Chandigarh 2
Changsha 2
City of London 2
Cormano 2
Denpasar 2
Dongguan 2
Edinburgh 2
Elk Grove Village 2
Fortaleza 2
Frascati 2
Guangzhou 2
Guayaquil 2
Ha Long 2
Haiphong 2
Houston 2
La Tronche 2
Lahore 2
Lima 2
Manama 2
Norwalk 2
Olomouc 2
Pune 2
Totale 1.287
Salva come PNG Salva come JPEG
Nome #
Correlation of frontal atrophy and CSF tau levels with neuropsychiatric symptoms in patients with cognitive impairment: a memory clinic experience 132
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 115
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial 114
Expression of selected microRNAs in migraine: A new class of possible biomarkers of disease? 104
Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study 101
Potential Contribution of Hypertension to Evolution of Chronic Migraine and Related Mechanisms 94
Differences in Trunk Acceleration-Derived Gait Indexes in Stroke Subjects with and without Stroke-Induced Immunosuppression 93
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 91
Correction to: Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study (The Journal of Headache and Pain, (2021), 22, 1, (114), 10.1186/s10194-021-01333-4) 91
BEHAVIORAL and PSYCHOLOGICAL SYMPTOMS in the CLINICAL PICTURE of DEMENTIA 87
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 84
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 83
null 80
High-frequency episodic migraine: Time for its recognition as a migraine subtype? 74
Association of anti‐calcitonin gene‐related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort study 73
Arterial hypertension in the chronic evolution of migraine: bystander or risk factor? An overview 73
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study 69
Pearls & Oy-sters: Marionette Walk in Parkinson Disease 64
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study 62
Oculo-vestibular signs in experimentally induced migraine attacks: an exploratory analysis 60
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 60
Searching for the Predictors of Response to BoNT-A in Migraine Using Machine Learning Approaches 58
Redefining migraine prevention: Early treatment with anti-CGRP monoclonal antibodies enhances response in the real world 53
Who cares about migraine? Pathways and hurdles in the European region - access to care III 43
Clinical and instrumental gait phenotyping in people with GLUT-1 deficiency syndrome 35
null 11
Real world effectiveness of anti-CGRP monoclonal antibodies over three consecutive one-year treatment cycles: An intention-to-treat analysis 9
miR-382-5p and miR-34a in migraine: Expression in monocytes and a post-hoc exploratory comparison with expression in peripheral blood mononuclear cells 9
Childhood traumas delineate a distinct psychological and clinical profile in adults with migraine: The hidden burden 7
SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study) 5
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study) 5
Setting higher standards for migraine prevention: A position statement of the International Headache Society 5
Guidelines of the International Headache Society for Real-World Evidence studies in migraine and cluster headache 4
Peripheral Endocannabinoid Components and Lipid Plasma Levels in Patients with Resistant Migraine and Co-Morbid Personality and Psychological Disorders: A Cross-Sectional Study 3
Peripheral Endocannabinoid Components and Lipid Plasma Levels in Patients with Resistant Migraine and Co-Morbid Personality and Psychological Disorders: A Cross-Sectional Study 3
Translation and validation of the Migraine Interictal Burden Scale (MIBS-4) in an Italian clinical cohort 3
Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study) 3
Exploring the Association of Migraine Susceptibility SNPs With the Risk of Chronic Migraine 2
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine 2
Evidence-based guidelines for the pharmacological treatment of migraine, summary version 2
Evidence-based guidelines for the pharmacological treatment of migraine 2
Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort 2
Effectiveness of transcranial direct current stimulation and monoclonal antibodies acting on the CGRP as a combined treatment for migraine (TACTIC): Results of a randomized controlled trial 2
Totale 2.072
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.076
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.076
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202221 0 0 0 0 0 0 0 3 1 3 1 13
2022/2023151 13 11 0 10 13 11 2 13 68 3 6 1
2023/202494 7 10 2 1 8 12 2 15 1 6 14 16
2024/2025513 11 13 9 2 11 71 55 28 120 34 68 91
2025/20261.151 95 57 99 123 154 37 172 66 122 88 105 33
2026/2027121 37 84 0 0 0 0 0 0 0 0 0 0
Totale 2.072